Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
Results Data were collected from 991 546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: ...
Rheumatoid arthritis was the most common diagnosis (80.9%), followed by systemic lupus erythematosus (13.3%), systemic sclerosis (4.4%), idiopathic inflammatory myopathies (1.8%), primary Sjögren ...
Background: Connective tissue disorders (CTDs) are a heterogeneous group of ... myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), SH, gastroesophageal reflux disease (GERD), hypothyroidism, ...
Another reason we think this is a great candidate for XGP is that, in our opinion, New Dawn got a bit of a bad rap at launch - and its mixed reception wasn't entirely deserved. Ubisoft tried to sell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results